(Q43295259)

18 November 2017

title

Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis (English)

1 reference

sclerosing encapsulating peritonitis

18 November 2017

main subject

1 reference

1 reference

Paolo Fabbrini

1

1 reference

18 November 2017

Margot N Schilte

2

1 reference

18 November 2017

Mammad Zareie

3

1 reference

18 November 2017

Piet M ter Wee

4

1 reference

18 November 2017

Eelco D Keuning

5

1 reference

18 November 2017

Robert H J Beelen

6

1 reference

18 November 2017

Jaap van den Born

7

1 reference

18 November 2017

language of work or name

English

0 references

publication date

7 August 2009

1 reference

Nephrology Dialysis Transplantation

18 November 2017

published in

1 reference

18 November 2017

volume

24

1 reference

18 November 2017

issue

12

1 reference

18 November 2017

page(s)

3669-3676

1 reference

The role of cyclooxygenases in inflammation, cancer, and development

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Cyclooxygenase-2: a therapeutic target in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP384

21 January 2018

Identifiers

DOI

10.1093/NDT/GFP384

1 reference

18 November 2017

1 reference